nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurandrenolide—Folliculitis—Vandetanib—thyroid cancer	0.136	0.151	CcSEcCtD
Flurandrenolide—Folliculitis—Sorafenib—thyroid cancer	0.092	0.102	CcSEcCtD
Flurandrenolide—Secondary infection—Epirubicin—thyroid cancer	0.0727	0.0804	CcSEcCtD
Flurandrenolide—Secondary infection—Doxorubicin—thyroid cancer	0.0673	0.0744	CcSEcCtD
Flurandrenolide—Leukoderma—Epirubicin—thyroid cancer	0.0503	0.0556	CcSEcCtD
Flurandrenolide—Leukoderma—Doxorubicin—thyroid cancer	0.0465	0.0514	CcSEcCtD
Flurandrenolide—Eruption—Epirubicin—thyroid cancer	0.0347	0.0384	CcSEcCtD
Flurandrenolide—Folliculitis—Epirubicin—thyroid cancer	0.034	0.0376	CcSEcCtD
Flurandrenolide—Eruption—Doxorubicin—thyroid cancer	0.0321	0.0355	CcSEcCtD
Flurandrenolide—Folliculitis—Doxorubicin—thyroid cancer	0.0314	0.0348	CcSEcCtD
Flurandrenolide—Infection—Vandetanib—thyroid cancer	0.0304	0.0336	CcSEcCtD
Flurandrenolide—Skin discolouration—Epirubicin—thyroid cancer	0.0237	0.0261	CcSEcCtD
Flurandrenolide—Skin discolouration—Doxorubicin—thyroid cancer	0.0219	0.0242	CcSEcCtD
Flurandrenolide—Pruritus—Vandetanib—thyroid cancer	0.0216	0.0239	CcSEcCtD
Flurandrenolide—Dermatitis contact—Epirubicin—thyroid cancer	0.0211	0.0233	CcSEcCtD
Flurandrenolide—Infection—Sorafenib—thyroid cancer	0.0205	0.0227	CcSEcCtD
Flurandrenolide—Dermatitis contact—Doxorubicin—thyroid cancer	0.0195	0.0216	CcSEcCtD
Flurandrenolide—Rash—Vandetanib—thyroid cancer	0.0193	0.0213	CcSEcCtD
Flurandrenolide—Dermatitis—Vandetanib—thyroid cancer	0.0193	0.0213	CcSEcCtD
Flurandrenolide—Hypersensitivity—Sorafenib—thyroid cancer	0.0152	0.0168	CcSEcCtD
Flurandrenolide—Pruritus—Sorafenib—thyroid cancer	0.0146	0.0161	CcSEcCtD
Flurandrenolide—Rash—Sorafenib—thyroid cancer	0.013	0.0144	CcSEcCtD
Flurandrenolide—Dermatitis—Sorafenib—thyroid cancer	0.013	0.0144	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.0085	0.0912	CbGpPWpGaD
Flurandrenolide—Infection—Epirubicin—thyroid cancer	0.00757	0.00837	CcSEcCtD
Flurandrenolide—NR3C1—Nuclear Receptors—THRB—thyroid cancer	0.00715	0.0767	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.00712	0.0764	CbGpPWpGaD
Flurandrenolide—Infection—Doxorubicin—thyroid cancer	0.00701	0.00775	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.00667	0.0715	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00565	0.0606	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Epirubicin—thyroid cancer	0.00562	0.00621	CcSEcCtD
Flurandrenolide—Pruritus—Epirubicin—thyroid cancer	0.00539	0.00596	CcSEcCtD
Flurandrenolide—Hypersensitivity—Doxorubicin—thyroid cancer	0.0052	0.00574	CcSEcCtD
Flurandrenolide—Pruritus—Doxorubicin—thyroid cancer	0.00499	0.00552	CcSEcCtD
Flurandrenolide—Rash—Epirubicin—thyroid cancer	0.00481	0.00531	CcSEcCtD
Flurandrenolide—Dermatitis—Epirubicin—thyroid cancer	0.0048	0.00531	CcSEcCtD
Flurandrenolide—NR3C1—Endoderm Differentiation—NKX2-1—thyroid cancer	0.00471	0.0505	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.0047	0.0504	CbGpPWpGaD
Flurandrenolide—Rash—Doxorubicin—thyroid cancer	0.00445	0.00492	CcSEcCtD
Flurandrenolide—Dermatitis—Doxorubicin—thyroid cancer	0.00444	0.00491	CcSEcCtD
Flurandrenolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—thyroid cancer	0.00325	0.0349	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.0031	0.0333	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—RXRA—thyroid cancer	0.00304	0.0326	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.00297	0.0319	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00248	0.0267	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.0024	0.0257	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00233	0.025	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00231	0.0248	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.00226	0.0242	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00201	0.0215	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.00192	0.0206	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.00168	0.018	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00154	0.0165	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00152	0.0163	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.00138	0.0148	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00135	0.0145	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00121	0.013	CbGpPWpGaD
Flurandrenolide—Drospirenone—PTGS2—thyroid cancer	0.00119	0.511	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.00114	0.0122	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.000976	0.0105	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000843	0.00904	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000836	0.00897	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000807	0.00866	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000729	0.00782	CbGpPWpGaD
Flurandrenolide—Betamethasone—PTGS2—thyroid cancer	0.00072	0.309	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000717	0.00769	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000674	0.00723	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.00065	0.00697	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.00062	0.00665	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000551	0.00591	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000485	0.00521	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—THRB—thyroid cancer	0.00047	0.00504	CbGpPWpGaD
Flurandrenolide—Dexamethasone—PTGS2—thyroid cancer	0.000419	0.18	CrCbGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000415	0.00445	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000414	0.00444	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.00041	0.0044	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—TPR—thyroid cancer	0.000317	0.0034	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—MEN1—thyroid cancer	0.000298	0.0032	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	0.000262	0.00281	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RXRA—thyroid cancer	0.0002	0.00214	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PPARG—thyroid cancer	0.000126	0.00135	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—AKT1—thyroid cancer	4.98e-05	0.000534	CbGpPWpGaD
